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ABSTR AC T

Background and study aims Despite the clinical efficacy
of peroral endoscopic myotomy (POEM), postoperative
symptomatic gastroesophageal reflux disease (GERD) remains a major concern. While it is known that length of
the gastric myotomy affects postoperative GERD, the clinical relevance of variation in esophageal myotomy length is
not well known. We performed a systematic review and
meta-analysis of studies comparing outcomes of short versus standard myotomy length in patients with achalasia.
Patients and methods We searched multiple databases
from inception through November 2020 to identify studies
that reported on outcomes of achalasia patients who underwent short compared with standard esophageal myotomy. Meta-analysis was performed to determine pooled
odds ratio (OR) of clinical success, GERD outcomes, and adverse events with the two techniques.
Results 5 studies with 474 patients were included in the final analysis (short myotomy group 214, standard myotomy
group 260). There was no difference in clinical success (OR
1.17, 95 % confidence interval [CI] 0.54–2.52; I2 0 %; P =
0.69), postoperative symptomatic GERD (OR 0.87, 95 %CI
0.44–1.74; I2 29 %; P = 0.70), and overall adverse events
(OR 0.52, 95 %CI 0.19–1.38; I2 40 %; P = 0.19), between the
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two groups. Incidence of postoperative erosive esophagitis
as determined by endoscopy was lower in the short myotomy group (OR 0.50, 95 %CI 0.24–1.03; I2 0 %; P = 0.06).

Introduction
Achalasia is a primary esophageal motor disorder, typically of
unclear etiology. The disorder is characterized by degeneration
of the myenteric plexus resulting in impaired relaxation of the
esophagogastric junction and loss of organized peristalsis in
the esophageal body causing patients to experience dysphagia,
esophageal dilation, food accumulation, and regurgitation [1].
Achalasia is a rare disease with a globally reported incidence
varying from 0.03 to 1.63 per 100 000 persons per year [2].
Treatment options include pharmacotherapy using muscle relaxants, endoscopic injection of botulinum toxin, pneumatic
balloon dilation, and laparoscopic Heller myotomy (LHM) [3].
Peroral endoscopic myotomy (POEM) is a novel and minimally
invasive therapeutic modality for achalasia and related disorders, which was first reported by Inoue et al. in 2010 [4]. While
studies have shown POEM to be as safe and effective, with
shorter recovery times and fewer serious complications compared with LHM [5, 6], guidelines suggest that both modalities
are comparable treatment options for management of patients
with achalasia types I and II [7].
Despite the clinical efficacy of POEM, postoperative symptomatic gastroesophageal reflux disease (GERD) remains a major
concern [8, 9]. A study comparing outcomes of LHM and POEM
found that at 3 months, 57 % of patients in the POEM group and
20 % of patients in the LHM group had reflux esophagitis, as assessed by endoscopy. The incidence at 24 months was 44 % and
29 %, respectively [10]. While several studies have identified
risk factors for post-POEM reflux such as female sex, presence
of preoperative esophagitis, as well as high preoperative Eckardt score, the effect of procedural factors such as overall
length of myotomy on post-procedure reflux is debatable [11,
12]. Based on the available evidence and following the tenets of
LHM, the actual myotomy length is recommended to be at least
6 cm (2 cm in the esophagus, 2–3 cm lower esophageal sphincter, 2 cm cardia) and on average between 8 and 10 cm [13]. The
length of the gastric myotomy and its effect on reflux has been
reported in the literature [14, 15]. At present, the clinical relevance of esophageal myotomy length is not well known. We
performed a systematic review and meta-analysis of studies
comparing outcomes of short vs. standard myotomy length in
patients with achalasia.

Patients and methods
Search strategy
The relevant medical literature was searched by a medical librarian for studies reporting outcomes of short vs. standard
myotomy in patients with achalasia. The search strategy was

Conclusion Our analysis showed that performing POEM
with short esophageal myotomy in achalasia was as safe
and effective as standard myotomy, with lower incidence
of postoperative erosive esophagitis.

created using a combination of keywords and standardized index terms. A systematic and detailed search was run in November 2020 in Ovid EBM Reviews, ClinicalTrials.gov, Ovid Embase
(from 1974), Ovid Medline (from 1946 including epub ahead of
print, in-process, and other non-indexed citations), Scopus
(from 1970), and Web of Science (from 1975). Results were
limited to English language only.
The full search strategy is available in Supplementary Appendix 1s. As the included studies were observational in design, the MOOSE (Meta-analyses Of Observational Studies in
Epidemiology) Checklist was followed [16] and is provided as
Supplementary Appendix 2s. The PRISMA checklist [17] and
PRISMA flow chart for study selection [18] were followed and
are provided as Supplementary Appendix 3s and Supplementary Fig. 1s, respectively. Reference lists of evaluated studies
were examined to identify other studies of interest.

Study selection
In this meta-analysis, we only included studies that compared
the clinical outcomes of short vs. standard esophageal myotomy in patients with achalasia. Studies included were randomized controlled trials (RCTs), cohort, and case–control studies
that reported outcomes of both treatment approaches. Studies
were included irrespective of whether they were published as
full manuscripts or conference abstracts, performed in inpatient or outpatient setting, follow-up time, and country of origin,
provided they included the appropriate data needed for the analysis.
Our exclusion criteria were as follows: 1) studies reporting
outcomes of POEM in non-achalasia disorders; 2) case reports
and case series studies; 2) studies with sample size < 10 patients; 3) studies performed in the pediatric population (age
< 18 years); and 4) studies not published in the English language. In cases of multiple publications from a single research
group reporting on the same patient cohort and/or overlapping
cohorts, data from the most recent and/or most appropriate
comprehensive report were retained. The remaining studies
were evaluated by two authors (S.C., D.R.) based on the publication timing (most recent) and/or the sample size of the study
(largest). In situations where a consensus could not be reached,
overlapping studies were included in the final analysis and any
potential effects were assessed by sensitivity analysis of the
pooled outcomes by leaving out one study at a time.

Data abstraction and quality assessment
Data on study-related outcomes from the individual studies
were abstracted independently onto a standardized form by at
least two authors (S.C., S.R.K.). Authors (A.P., B.D., D.R.) crossverified the collected data for possible errors, and two authors
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(S.C., S.R.K.) performed the quality scoring independently. We
used the Newcastle–Ottawa scale to assess the quality of cohort studies [19]. This quality score consisted of eight questions, the details of which are provided in Supplementary Table
1s. For RCTs, we used the Cochrane Collaboration tool to assess
risk of bias (Supplementary Appendix 4s) [20]. The quality of
evidence was assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) methodology and is depicted as per Supplementary Fig. 2s [21].

Outcomes assessed
Patients were grouped based on the intervention they received:
short esophageal myotomy or standard esophageal myotomy.
The following outcomes were assessed:
1. pooled odds ratio [OR] and proportion of clinical success
(defined as postoperative Eckardt score < 3 [22–25] or
< 4 [26])
2. pooled OR and proportion of symptomatic postoperative
GERD
3. pooled OR and proportion of postoperative erosive esophagitis as determined by endoscopic evaluation
4. pooled OR and proportion of overall adverse events
5. pooled OR and proportion of mucosal injury in both groups
6. pooled means of length of hospital stay (LOS) in both
groups.

Statistical analysis
We used meta-analysis techniques to calculate the pooled estimates in each case following the methods suggested by DerSimonian and Laird using the random-effects model and results
were expressed in terms of odds ratio (OR) or mean difference
along with relevant 95 % confidence intervals (CIs), when appropriate [27]. When the incidence of an outcome was zero in
a study, a continuity correction of 0.5 was added to the number
of incident cases before statistical analysis.
We assessed heterogeneity between study-specific estimates by using Cochran Q statistical test for heterogeneity, 95
%CIs, and the I2 statistics [28–30]. Values of < 30 %, 30 %–60 %,
61 %–75 %, and > 75 % were suggestive of low, moderate, substantial, and considerable heterogeneity, respectively. We assessed publication bias qualitatively, by visual inspection of funnel plot, and quantitatively, by the Egger test [31]. When publication bias was present, further statistics using the fail-Safe N
test and Duval and Tweedie’s “Trim and Fill” test was used to
ascertain the impact of the bias [32].
Given the low number of included studies, a Knapp–Hartung
two-tailed P value of < 0.10 was considered statistically significant and R 2 value was calculated to study the goodness-of-fit
[33]. All analyses were performed using RevMan version 5
from the Cochrane collaboration (Cochrane Collaboration, Copenhagen, Denmark) and OpenMeta [Analyst] software.

E1248

Results
Characteristics and quality of included studies
Five studies were included in the final analysis [22–26]. Two of
the included studies were retrospective in design [24, 25] and
two were prospective RCTs [22, 23]. One of the studies was
published in abstract form, presenting interim analyses [26].
Three studies were performed in China, one in Europe, and
one in India. Based on the Newcastle–Ottawa scoring system,
both observational cohort studies were considered to be of
high quality (Supplementary Table 1s).

Search results and population characteristics
All search results were exported to Endnote where 5536 obvious duplicates were removed leaving 4666 citations. Five
studies with a total of 474 patients were included in the final analysis. A schematic diagram demonstrating our study selection is illustrated in Supplementary Fig. 1s.
A total of 214 patients underwent POEM with a short esophageal myotomy, ranging from 2.76 cm to 5 cm, and 260 patients underwent a standard esophageal myotomy, ranging
from 6.9 cm to 10 cm. Across all studies, the mean gastric
myotomy length was kept the same in both the short and
standard groups, ranging from 2 cm to 3.2 cm [22–26]. Details
of patient characteristics and demographics were available in
all five studies. A total of 238 males and 236 females were included in our analysis. The etiology was Type I achalasia in 106
patients, Type II in 364 patients, and Type III in 4 patients. Mean
age ranged from 37.7 years to 49.3 years. LOS ranged from
2.81 to 9.9 days. Mean follow-up time ranged from 8.09 to
26.8 months in the short myotomy group and from 8.3 to 29.5
months in the standard myotomy group.
Further details of patient characteristics, prior therapeutic
interventions (botulinum toxin, pneumatic dilation, and/or
LHM) are described in ▶ Table 1 and ▶ Table 2.

Meta-analysis outcomes
1. The pooled rate of clinical success was 95.1 % (95 %CI 91.4–
98.7) in the short myotomy group and 93.3 % (95 %CI 89.1–
97.5) in the standard myotomy group. There was no statistically significant difference between the two groups (OR
1.17, 95 %CI 0.54–2.52; I 2 0 %; P = 0.69) (▶ Fig. 1).
2. The pooled rate of symptomatic postoperative GERD was
22.6 % (95 %CI 5.6–39.6) in the short myotomy group and
20.2 % (95 %CI 10.8–29.5) in the standard myotomy group.
There was no statistically significant difference between the
two groups (OR 0.87, 95 %CI 0.44–1.74; I2 29 %; P = 0.70)
(▶ Fig. 2).
3. The pooled rate of postoperative erosive esophagitis as determined by endoscopy was 12.4 % (95 %CI 0–25.2) in the
short myotomy group and 22.3 % (95 %CI 3.3–41.4) in the
standard myotomy group. The difference between the two
groups was statistically significant (OR 0.50, 95 %CI 0.24–
1.03; I2 0 %; P = 0.06) (▶ Fig. 3).
4. The pooled rate of overall adverse events was 6.5 % (95 %CI
0.6–12.4) in the short myotomy group and 12.5 % (95 %CI
1.9–23.1) in the standard myotomy group. There was no
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Retrospective, Jul
2011–Sep
2017, single
center,
China

Prospective,
RCT, single
blinded, Feb
2018–Feb
2019, single
center,
China

Prospective,
RCT, double
blinded, Jun
2017–Mar
2019, India

RCT, Nov
2015 single
center, Italy

Huang,
2020 [24]

Gu, 2020
[22]

Nabi,
2020 [23]

Familiari,
2016 [26]
(abstract)

74

48

37

36

46

34

38

63

63

35

Standard

Short

Patients

I 8, II 27

I 12, II
22

II 46

I 12, II
24

I 16, II
45, III 2

Short

type)

I 10, II 28

I 13, II 24

II 48

I 26, II 48

I 9, II 52, III 2

Standard

Etiology (achalasia

46.8
(15.4)

40.1
(16.8)

43.6
(11.4)

40.8
(11.1)
[16–68]

49.3
[19–79]

Short

years

45.9 (13.9)

41.3 (14.4)

19/16

18/16

21/25

19/17

37.7 (13)
[8–74]

42.8 (10.2)

24/39

Short

20/18

24/13

23/25

40/34

30/33

Standard

Male/female

45.9 [16–
72]

Standard

Age, mean (SD) [range],

SD, standard deviation; BD, balloon dilation; Btx, botulinum toxin injection; HM, Heller myotomy; PD, pneumatic dilation.

Retrospective, Jan
2013–Dec
2016, single
center,
China

Design

Li, 2019
[25]

[ref]

Study

▶ Table 1 Study details – population characteristics.

4.3
(5.85)

3 [1.5–
4.7]

5.0
[0.3–
34.0]

8.8
(5.5)
[2–25]

9.4
[0.1–
40.0]

Short

BD 7,
Btx 2

0

8.9 (5.8)
[3–30]

4.1
[0.3–31.0]

3.49 (6.44)

Btx 2,
PD 6

PD 12

BD 13,
Btx 8,
HM 1,
BD +
Btx 1

9.4
[0.3–30.0]

3 [1–5]

Short

Btx 1, PD 2

PD 9

0

BD 9, Btx 3

BD 10, Btx 3,
Stent 1, HM
1, BD + Btx 2,
Btx + Stent 2

Standard

Previous treatments

Standard

(SD) [range], years

Disease duration, mean

E1250

E 2.76
(0.41), G
2.70 (0.73)

8 (0.6) [7–
9] [Total],
E 5 [3–6],
G3 [1–4]

72.43
(27.28)

59.2 (16.7)
[30–106]

44.03
(13.78)

47.7
(13.2)
[24–
85]

Familiari,
2016
(abstract)

55/63

68/74

45/48

32/33

56/63

34/36

44/46

29/31

32/32

9.2 (8–11)
[Total],
E 6.9 [5–9],
G 2.3 [2–4]

11.5 (3.1)
[8–25] [Total],
E 8.2 (2.7)
[6–20], G
3.2 (1.2)
[2–5]
10.14
(0.54) [Total],
E [7–8], G
[2–3]
E 7.97
(2.40), G
2.84 (0.63)

13 (1) [11–
15] [Total],
E 10 [7–
11], G3 [2–
5]
28/29

Standard

Short

Standard

Clinical success

Outcomes

15/27
(symptomatic)

11/34
(EGD); 7/
27 (pH)

7/46
(symptomatic); 4/
46 (EGD);
11/46 (pH)

3/36
(symptomatic); 1/
36 (EGD)

6/63
(symptomatic)

Short

2.6
(0.9)
[2–4]

2.82
(0.67)
4/37 [Total], (Mucosal inj 1,
PneumoP
3)
4/34 [Total],
(Mucosal
inj 1, PneumoP 3)
18/37
(EGD); 12/
20 (pH)

PneumoP
1, Mucosal
perforation
1, Ulcers 6

2.81
(0.70)

7.0
(0.9)
1/48 [Total], (Mucosal inj 1)
0/46 [Total],
(Mucosal
inj 0)

11/48
(symptomatic); 7/
48 (EGD);
21/48 (pH)

PneumoP
0, Mucosal
perforation
0, Ulcers 5

6.5
(1.6)

9.9
(2.4)
[5–14]

6/74 [Total], (Mucosal inj 1,
PneumoT
2, Major
bleeding 3)

3/36 [Total],
(Mucosal
inj 0, PneumoT 1, Major bleeding 2)

11/74
(symptomatic); 6/
74 (EGD)

10/21
(symptomatic)

9.3
(2.9)
[5–15]

NR

21/63 [Total],
(PneumoP
3, PneumoM 1,
Mucosal inj
5, Major
bleeding 0)

6/63 [Total],
(PneumoP
2, PneumoM 0,
Mucosal inj
4, Major
bleeding 0)

2.3
(0.7)
[2–4]

NR

ard
8/63
(symptomatic)

Stand-

Short

Standard

Short

Adverse events

Standard

Postoperative GERD

[range], days

LOS, mean (SD)

8.09
(3.05)
[6–12]

12

12

26.8
[8–
54.3]

20.1
[6–48]

Short

months

8.3
(2.9)
[6–12]

12

12

29.5
[6–
58.8]

23.6
[6–48]

ard

Stand-

(SD) [range],

Follow-up, mean

SD, standard deviation; GERD, gastroesophageal reflux disease; LOS, length of hospital stay; PneumoP, pneumoperitoneum; PneumoM, pneumomediastinum; PneumoT, pneumothorax; NR, not reported; EGD, esophagogastroduodenoscopy.

5.66 (0.14)
[Total],
E [3–4], G
[2–3]

Nabi,
2020

45.6 (16.2)

31.2
(15.3)

Gu, 2020

6.0 (0.6)
[5.0–7.0]
[Total],
E 4.0 (0.7)
[3–6], G
2.1 (0.3)
[1–3]

62.1 (25.2)
[30.0–180]

46.6
(18.5)
[20.0–
100.0]

4.8 [3–6]
[Total],
E 2.9 [2–4],
G 2.0 [1–3]

49.2 [23–
120]

Huang,
2020

Short

Standard

39.5
[21–
74]

Short

Esophageal, G-Gastric,

mean (SD) [range], cm

Myotomy length, E-

Operative time, mean

(SD) [range], minutes

Li, 2019

Study

▶ Table 2 Procedure and outcome details.
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Short myotomy Standard myotomy
Study or Subgroup

Events

Total

Events Total

Familiari 2016

26

26

23

23

Gu 2020

44

46

45

48

Odds Ratio

Odds Ratio

Weight M-H, Random, 95% CI
Not estimable
17.6 %

1.47 [0.23, 9.21]

Huang 2020

34

36

68

74

21.7 %

1.50 [0.29, 7.83]

Li 2019

56

63

55

63

50.8 %

1.16 [0.39, 3.43]

Nabi 2020

29

31

32

33

9.9 %

0.45 [0.04, 5.26]

241

100.0 %

1.17 [0.54, 2.52]

Total (95 % CI)
Total events

202
189

M-H, Random, 95% CI

223

Heterogeneity: Tau2 = 0.00; Chi2 = 0.72, df = 3 (P = 0.87); I2 = 0 %

0.01
0.1
1
Favors standard myotomy

Test for overall eﬀect: Z = 0.39 (P = 0.69)

10
100
Favors short myotomy

▶ Fig. 1 Forest plot, clinical success. M-H, Mantel-Haenszel; CI, confidence interval.

Short myotomy Standard myotomy
Study or Subgroup
Familiari 2016

Events Total

Events Total

Odds Ratio

Odds Ratio

Weight M-H, Random, 95% CI

17

26

10

23

25.1 %

2.46 [0.77, 7.79]

Gu 2020

7

46

11

48

28.7 %

0.60 [0.21, 1.72]

Huang 2020

3

36

11

74

20.1 %

0.52 [0.14, 2.00]

Li 2019

6

63

8

63

26.2 %

0.72 [0.24, 2.22]

208

100.0 %

0.87 [0.44, 1.74]

Total (95 % CI)
Total events

171
33

M-H, Random, 95% CI

40

Heterogeneity: Tau2 = 0.14; Chi2 = 4.23, df = 3 (P = 0.24); I2 = 29 %
0.01

Test for overall eﬀect: Z = 0.38 (P = 0.70)

0.1
Favors short myotomy

1

10
100
Favors standard myotomy

▶ Fig. 2 Forest plot, postoperative symptomatic gastroesophageal reflux disease. M-H, Mantel-Haenszel; CI, confidence interval.

Short myotomy Standard myotomy
Study or Subgroup

Events Total

Events Total

Odds Ratio

Odds Ratio

Weight M-H, Random, 95% CI

Gu 2020

4

46

7

48

31.4 %

Huang 2020

1

36

6

74

11.5 %

0.32 [0.04, 2.80]

11

34

18

37

57.1 %

0.50 [0.19, 1.33]

159

100.0 %

0.50 [0.24, 1.03]

Nabi 2020
Total (95 % CI)
Total events

116
16

M-H, Random, 95% CI

0.56 [0.15, 2.05]

31

Heterogeneity: Tau2 = 0.00; Chi2 = 0.18, df = 2 (P = 0.91); I2 = 0 %
Test for overall eﬀect: Z = 1.89 (P = 0.06)

0.01

0.1
Favors short myotomy

1

10
100
Favors standard myotomy

▶ Fig. 3 Forest plot, postoperative erosive esophagitis. M-H, Mantel-Haenszel; CI, confidence interval.

statistically significant difference between the two groups
(OR 0.52, 95 %CI 0.19–1.38; I2 40 %; P = 0.19) (Supplementary Fig. 3s).
5. The pooled rate of mucosal injury was 2 % (95 %CI 0–4) in the
short myotomy group and 2.4 % (95 %CI 0.3–4.4) in the
standard myotomy group. There was no statistically significant difference between the two groups (OR 0.74, 95 %CI
0.25–2.17; I2 0 %; P = 0.58) (Supplementary Fig. 4s).
6. The pooled mean LOS was 6.55 days (95 %CI 2.98–10.12) in
the short myotomy group and 6.19 days (95 %CI 2.47–9.91)

in the standard myotomy group. There was no statistically
significant difference between the two groups (OR 0.25,
95 %CI –0.14 to 0.63; I2 37 %; P = 0.21) (Supplementary
Fig. 5s). All outcomes with I2 values are summarized in
▶ Table 3.
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▶ Table 3 Summary of pooled results.
Outcome/group

Pooled proportion, % (95 %CI)

OR (95 %CI),
P value, I2

Short myotomy

Standard myotomy

Clinical success

95.1 (91.4–98.7)

93.3 (89.1–97.5)

1.17 (0.54–2.52),
P = 0.69, I2 0 %

Postoperative GERD (symptomatic)

22.6 (5.6–39.6)

20.2 (10.8–29.5)

0.87 (0.44–1.74),
P = 0.70, I2 29 %

Postoperative GERD (EGD)

12.4 (0–25.2)

22.3 (3.3–41.4)

0.50 (0.24–1.03),
P = 0.06, I2 0 %

12.5 (1.9–23.1)

0.52 (0.19–1.38),
P = 0.19, I2 40 %

Total adverse events

6.5 (0.6–12.4)

Mucosal injury

2 (0–4)

2.4 (0.3–4.4)

0.74 (0.25–2.17),
P = 0.58, I2 0 %

Length of stay

6.55 (2.98–10.12)

6.19 (2.47–9.91)

0.25 (–0.14–0.63),
P = 0.21, I2 37 %

CI, confidence interval; OR, odds ratio; GERD, gastroesophageal reflux disease; EGD, esophagogastroduodenoscopy.

Validation of meta-analysis results
Sensitivity analysis
To assess whether any one study had a dominant effect on the
meta-analysis, we excluded one study at a time and analyzed its
effect on the main summary estimate. We analyzed the effect
of excluding the study by Familiari et al., published as an abstract, on clinical success. We found that exclusion of this study
did not significantly affect the primary outcome or influence
the heterogeneity.

Heterogeneity
We assessed dispersion of the calculated rates using the I2 percentage values as reported in the meta-analysis outcomes section. While the overall the heterogeneity was low, there was
evidence of moderate heterogeneity in our secondary end
points (i. e. overall adverse events and LOS).

Publication bias
Based on visual inspection of the funnel plot for clinical success
and GERD outcomes, there was no evidence of publication bias
(Supplementary Fig. 6s).

Discussion
Our analysis shows that performing POEM with a shorter esophageal myotomy length in patients with achalasia is noninferior
to standard length myotomy. While the incidence of postoperative symptomatic GERD was similar between the two groups,
patients with shorter myotomies were statistically less likely to
have endoscopic evidence of erosive esophagitis. The overall
rates of adverse events, risk of mucosal injuries, and LOS were
similar between the two groups of patients.
Since the first reports over a decade ago [4], POEM has become a standard treatment for achalasia and related disorders
worldwide owing to its less invasive nature and higher curative
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effect than conventional therapeutic methods [34]. Despite the
clinical efficacy of POEM, post-procedure GERD remains one of
the most frequent complications encountered in clinical practice. Current evidence suggests that symptomatic GERD occurs
in 8.5 %–19 % of patients, while endoscopic findings of erosive
esophagitis are detected in 13 %–29.4 % of patients post-procedure [35–37]. Several procedural modifications have been
made to POEM in an attempt to make the procedure safer,
more effective, and the results more highly reproducible.
Some of these modifications include a change in the myotomy
approach (full thickness – when all muscle layers are cut; partial
thickness – when only the circular layer is cut), location of the
tunneling (anterior wall between 1 and 2 o’clock position; posterior wall between 5 and 6 o’clock position), and length of
myotomy (long ≥ 7 cm; or short < 7 cm). While studies have
shown that a gastric myotomy length of more than 2.5 cm results in increased rates of moderate esophagitis without improving overall clinical efficacy [15], the effect of altering
esophageal myotomy length is not well established. Our study
is the first in the literature to assess the effect of esophageal
myotomy length on postoperative GERD and to analyze its effect on the clinical effectiveness of POEM.
Some of the commonly reported complications of POEM include mucosal perforations [38, 39], pneumothorax [40], pneumoperitoneum [41, 42], pneumomediastinum [43], and subcutaneous emphysema [39, 40, 43]. In our analysis, we found that
while overall adverse events occurred in a greater proportion of
patients undergoing standard length myotomy compared with
those undergoing short myotomy, the difference between the
two groups was not statistically significant. It is important to
note that the operative time across studies was significantly
longer when performing standard esophageal myotomy
(45.6–72.43 vs. 31.2–47.7 minutes). We found no statistical
difference in the pooled rates of mucosal injury between the
two groups (2 % vs. 2.4 %; P = 0.58). Pneumoperitoneum was reported five patients, pneumothorax in one patient, and major
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bleeding in two patients in the short myotomy group. Finally,
we found no difference in the overall LOS between the two
groups.
There are several strengths to our review. First, we included
only those studies where outcomes of short myotomy length
were compared with those of the standard technique, including
three RCTs [22, 23, 26]. This allowed us to perform a more robust meta-analysis of procedural outcomes. Second, given the
significant differences in the incidence of GERD as assessed by
symptomology, endoscopic evidence and pH monitoring [44],
we calculated the pooled rates of symptomatic and erosive
esophagitis separately. Third, we conducted a systematic literature search with well-defined inclusion criteria, careful exclusion of redundant studies, inclusion of good quality studies
with detailed extraction of data and rigorous evaluation of
study quality. Finally, we excluded all studies in which POEM
was performed for non-achalasia indications such as jackhammer esophagus and diffuse esophageal spasm because of the
variable lengths of myotomy in these conditions [45].
There are several limitations to this study, most of which are
inherent to any meta-analysis. First, one of the included studies
in our analysis only reported interim outcomes at 6 months
[26], two studies reported outcomes at 12 months [22, 23],
and two studies reported outcomes beyond 20 months [24,
25]. The mean follow-up period varied across studies, ranging
from 8.09 months to 29.5 months. While the overwhelming
majority of patients (n = 364) included in our analysis had Type
II achalasia, four patients had Type III achalasia. Although not
standardized, a longer myotomy is thought to be more effective at controlling symptoms caused by the esophageal spasm
of type III achalasia [7, 45, 46]. One of the included studies was
published only in abstract format [26]. We contacted the authors via email to obtain details about patient characteristics
and procedure outcomes, as reported in our study. However,
we were informed that the trial is ongoing at this time. We
were unable to compare short and long esophageal myotomy
groups in terms of objective pH-based outcomes of GERD (i. e.
24-hour pH-impendence results), as this information was
provided in only two trials [22, 23]. Two of the studies included
in our analysis were retrospective in design, and while they
were both of high quality, their inclusion could have resulted
in selection bias. The absence of blinding of outcome assessment by Gu et al. could have resulted in detection bias. Finally,
we were unable to assess risk of bias in the study by Familiari et
al., as it was only published as an abstract.
In conclusion, our study showed that performing POEM with
short esophageal myotomy length appeared to be as clinically
effective as standard myotomy. Both approaches had similar
safety profiles. While incidence of symptomatic GERD was comparable between the two techniques, erosive esophagitis tended to occur less frequently with the short myotomy approach. It
is important to note that statistical nonsignificance may not be
an indication of equivalence but rather of uncertainty. Further
RCTs with longer follow-up times are needed to validate our results.
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